We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Several national patent term extension proceedings regarding fixed-combination medicinal products have been stayed in Europe since UK courts have referred two cases to the highest European courtthe Court of Justice of the European Union
